REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

FDA Peptide Drugs

Browse FDA-registered peptide and peptide-derived drugs. Filter by category or search by brand or generic name.

49 Results

Adlyxin

Lixisenatide

DRUG

Sanofi US

SUBCUTANEOUS INJECTION

Bydureon BCise

Exenatide Extended Release

DRUG

AstraZeneca

SUBCUTANEOUS INJECTION

Byetta

Exenatide

DRUG

AstraZeneca

SUBCUTANEOUS INJECTION

Cetrotide

Cetrorelix

DRUG

EMD Serono (Merck KGaA)

SUBCUTANEOUS INJECTION

Cortrosyn

Cosyntropin

DRUG

Amphastar Pharmaceuticals

IV / IM INJECTION

Egrifta SV

Tesamorelin

DRUG

Theratechnologies Inc.

SUBCUTANEOUS INJECTION

Factrel

Gonadorelin

DRUG

Pfizer Inc.

SUBCUTANEOUS / IV INJECTION

Firmagon

Degarelix

DRUG

Ferring Pharmaceuticals Inc.

SUBCUTANEOUS INJECTION

Forteo

Teriparatide (PTH 1-34)

DRUG

Eli Lilly and Company

SUBCUTANEOUS INJECTION

Ganirelix Acetate

Ganirelix

DRUG

Organon USA Inc.

SUBCUTANEOUS INJECTION

Genotropin

Somatropin (recombinant HGH)

DRUG

Pfizer Inc.

SUBCUTANEOUS INJECTION

Geref (discontinued)

Sermorelin

DRUG

EMD Serono (Merck KGaA)

SUBCUTANEOUS INJECTION

H.P. Acthar Gel

Corticotropin (ACTH)

DRUG

Mallinckrodt ARD LLC

IM / SC INJECTION

Humatrope

Somatropin (recombinant HGH)

DRUG

Eli Lilly and Company

SUBCUTANEOUS INJECTION

Imcivree

Setmelanotide

DRUG

Rhythm Pharmaceuticals Inc.

SUBCUTANEOUS INJECTION

Increlex

Mecasermin

DRUG

Ipsen Biopharmaceuticals Inc.

SUBCUTANEOUS INJECTION

Korsuva

Difelikefalin

DRUG

Vifor Pharma / CSL Behring

IV INJECTION

Linzess

Linaclotide

DRUG

AbbVie / Ironwood Pharmaceuticals

ORAL CAPSULE

Lupron / Lupron Depot

Leuprolide

DRUG

AbbVie Inc.

IM INJECTION (DEPOT)

Miacalcin / Fortical

Calcitonin (salmon)

DRUG

Various (Novartis / Upsher-Smith)

NASAL SPRAY / SC INJECTION
Prev1 / 3Next

Data Source: Drug data is sourced from the openFDA API. This data may not reflect the most current information. Always verify drug information with official FDA resources or a licensed healthcare professional.

Peptide Contacts provides research-based summaries for informational purposes only. We do not host, distribute, or endorse vendor documentation. All certificates of analysis, GMP certificates, and vendor communications must be requested and verified directly by the buyer. Nothing on this platform constitutes legal, medical, or professional advice. Users are solely responsible for verifying vendor credentials and ensuring compliance with all applicable local, state, and federal laws before purchasing any research chemicals. Use of this platform constitutes acceptance of full personal responsibility.